Linden Thomas Advisory Services LLC Sells 907 Shares of National Research Co. (NASDAQ:NRC)

Linden Thomas Advisory Services LLC trimmed its stake in National Research Co. (NASDAQ:NRC) by 3.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 27,157 shares of the company’s stock after selling 907 shares during the period. Linden Thomas Advisory Services LLC’s holdings in National Research were worth $479,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Quarry LP bought a new stake in shares of National Research during the second quarter worth $54,000. FMR LLC grew its holdings in shares of National Research by 397.3% during the third quarter. FMR LLC now owns 2,944 shares of the company’s stock worth $67,000 after purchasing an additional 2,352 shares during the last quarter. Gladius Capital Management LP grew its holdings in shares of National Research by 164.5% during the third quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock worth $70,000 after purchasing an additional 1,908 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in shares of National Research during the third quarter worth $88,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of National Research during the third quarter worth $96,000. 47.26% of the stock is currently owned by institutional investors.

National Research Price Performance

Shares of NRC stock opened at $17.96 on Monday. The stock’s fifty day moving average is $18.15 and its 200-day moving average is $20.24. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. The stock has a market capitalization of $421.70 million, a PE ratio of 15.89 and a beta of 0.53. National Research Co. has a 52 week low of $16.50 and a 52 week high of $42.00.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Friday, October 25th. The company reported $0.24 earnings per share (EPS) for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The business had revenue of $35.82 million for the quarter.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.